ArticleThe Journal of infection2022

Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients.

Maria Paz Ventero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.